Advertisement
Product › Details
Atrosab
Next higher product group | anti-inflammatory drug_o | |
Status | 2012-03-13 development pp existent | |
Organisation | Baliopharm GmbH | |
Today | Alvotech Germany GmbH | |
Group | Alvogen (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for anti-inflammatory drug_o
- [1] Amgen Inc.. (8/4/22). "Press Release: Amgen to Acquire ChemoCentryx for $4 Billion in Cash". Thousand Oaks, CA & San Carlos, CA....
- [2] Rnatics GmbH. (1/13/22). "Press Release: Rnatics Granted € 7 Million for the Clinical Development of a New COVID-19 Drug"....
- [3] MoonLake Immunotherapeutics AG. (5/6/21). "Press Release: MoonLake Immunotherapeutics Announces Publication in The Lancet". Zug....
- [4] Eleva GmbH. (1/6/21). "Press Release: Eleva Secures up to EUR 60 Million to Advance a Drug Candidate, Appoints New Board Member". Freiburg....
- [5] Immune Regulation Ltd.. (9/21/20). "Press Release: Immune Regulation Limited Raises £40.6 Million / $53.4 Million Series B Equity Financing". London & Boston, MA....
- [6] AM-Pharma B.V.. (3/31/20). "Press Release: AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI". Utrecht....
- [7] ChemoCentryx Inc.. (11/25/19). "Press Release: ChemoCentryx and VFMCRP Announce Positive Topline Data from Pivotal Phase III ADVOCATE Trial Demonstrating Avacopan’s Superiority Over Standard of Care in ANCA-Associated Vasculitis". Mountain View, CA & St...
- [8] Novartis AG. (7/19/19). "Press Release: Novartis Key Multiple Sclerosis Product Gilenya Approved in China". Basel....
- [9] AM-Pharma B.V.. (7/16/19). "Press Release: AM-Pharma Raises €116m ($133m) to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury". Bunnik....
- [10] Novartis AG. (4/2/19). "Press Release: Novartis First-in-class Cosentyx Approved in China for Psoriasis Patients". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top